288 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Rank Status Study
21 Available Epidiolex and Drug Resistant Epilepsy in Children
Condition: Epilepsy
Intervention: Drug: Cannabidiol (Epidiolex)
22 Available Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)
Condition: Heart Failure With Reduced Ejection Fraction
Intervention: Drug: LCZ696
23 Temporarily not available Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Autologous Adipose-Tissue Derived Stem Cells
24 Available An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency
Condition: Lysosomal Acid Lipase Deficiency
Intervention: Drug: sebelipase alfa
25 Available Expanded Access Treatment Protocol CA204-143
Condition: Multiple Myeloma
Intervention: Drug: Elotuzumab
26 Available 68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial
Condition: Neuroendocrine Tumors
Intervention: Drug: 68Ga-DOTATOC PET/CT Scan
27 Temporarily not available An Open Protocol for the Compassionate Use of Trametinib
Condition: Cancer
Intervention: Drug: Trametinib
28 Available OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy
Condition: Thrombotic Microangiopathy
Intervention: Biological: OMS721
29 Temporarily not available Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study
Condition: Cancer of the Prostate
Intervention: Drug: C-11 Choline PET Imaging
30 No longer available TX2® Low Profile Endovascular Graft
Conditions: Aortic Aneurysm;   Penetrating Ulcer;   Vascular Disease
Intervention: Device: TX2® Low Profile TAA Endovascular Graft
31 Available A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Intravenous (IV) citrulline
32 Temporarily not available FMT for Multidrug Resistant Organism Reversal
Condition: Infection With Multi-drug Resistant Organisms
Intervention: Biological: Fecal microbiota transplantation (FMT)
33 Available Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
Condition: CD33 Positive Acute Myelogenous Leukemia
Intervention: Biological: Antibody Drug Conjugate Chemotherapeutic
34 No longer available Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France
Conditions: Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma
Interventions: Drug: Ramucirumab;   Drug: Paclitaxel
35 Temporarily not available Extended Access Program for Subjects Completing Perampanel Study E2007-G000-332
Condition: Seizure Disorder Generalized Tonic Clonic
Intervention: Drug: Perampanel
36 No longer available Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]
Condition: Leber's Hereditary Optic Neuropathy
Intervention: Drug: EPI-743
37 No longer available A Single Patient IND for PD-0325901
Condition: Prior Treatment With PD-0325901 With Ongoing Clinical Response
Intervention: Drug: PD-0325901
38 Available Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma
Condition: Unresected Stage IIIB to IVM1c Melanoma
Intervention: Drug: Talimogene Laherparepvec
39 Available Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer Metastatic
Intervention: Drug: TAS-102
40 Available Expanded Access Protocol Thymus Transplantation
Conditions: Poor Thymic Function;   Immunodeficiency;   Athymia;   Immunoreconstitution;   Thymus Transplantation;   Low T Cell Numbers
Interventions: Biological: Thymus Transplantation;   Procedure: Blood Draw;   Drug: Rabbit Anti-Thymocyte Globulin and Cyclosporine or Tacrolimus

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years